Laredo Health Department hosts FREE At-Home COVID-19 Tests

Translate to Spanish or other 102 languages!

The City of Laredo Health Department will host its first-ever pop-up to give free at-home COVID-19 tests to the community. The Laredo Health Department will be at the intersection of Guadalupe and Meadow giving out free at-home COVID-19 tests – acquired by Gateway Community Health Center. Image for illustration purposes
The City of Laredo Health Department will host its first-ever pop-up to give free at-home COVID-19 tests to the community. The Laredo Health Department will be at the intersection of Guadalupe and Meadow giving out free at-home COVID-19 tests – acquired by Gateway Community Health Center. Image for illustration purposes

Mega Doctor News

- Advertisement -

LAREDO, Texas— The City of Laredo Health Department will host its first-ever pop-up to give free at-home COVID-19 tests to the community. The Laredo Health Department will be at the intersection of Guadalupe and Meadow giving out free at-home COVID-19 tests – acquired by Gateway Community Health Center.

WHO:            City of Laredo Health Department

WHAT:          FREE at-home COVID-19 Tests

- Advertisement -

WHEN:          Saturday, July 9, 2022, from 9:00 – 11:00 AM

WHERE:        Intersection of Guadalupe and Meadow

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

What Persistent Fatigue Might Be Telling You

Mega Doctor News CLEVELAND CLINIC - We’ve all had those days where we’re...

AMA Unveils New Initiative to Boost Nutrition Education Nationwide

The American Medical Association (AMA) is launching a nutrition education initiative to equip physicians and medical students with practical, evidence-based knowledge and tools to help patients live healthier lives.

DHR Health to Host Headache Symposium to Address Gap in Neurological Care, March 28th

In the United States, headaches remain a common health concern, affecting approximately one in six Americans. Migraines, a type of headache, are the second leading cause of years lived with disability nationwide.

Study Finds GLP‑1 Therapy Reduces Heart and Kidney Risks for Type 1 Diabetes Patients

People with type 1 diabetes who took GLP-1 receptor agonist (GLP-1-RA) drugs for weight loss or better blood-sugar control had significantly reduced risks of major cardiovascular events and end-stage kidney disease without any increase in safety concerns, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
- Advertisement -